###begin article-title 0
###xml 147 151 <span type="species:ncbi:10116">rats</span>
Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1alpha by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 518 519 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
T-cells extravasation and CNS parenchyma infiltration during autoimmune neurodegenerative disease can be evoked by local antigen presenting cells. Studying the chemoattracting potential of spinal perivascular macrophages (SPM) during experimental allergic encephalomyelitis (EAE), we observed numerous infiltrates of densely-packed mononuclear cells. Apart from the poor spatial and optical resolution, no differentiation between the resident SPM (mabs ED1+, ED2+) and the just recruited monocytes/macrophages (mab ED1+) was possible.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 437 438 437 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 444 445 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
This is why we labeled SPM by injections of different fluoresecent dyes into the lateral cerebral ventricle before induction of active EAE. Within an additional experimental set EAE was induced by an intraperitoneal injection of T-cells specifically sensitized to myelin basic protein (MBP) and engineered to express the green fluorescent protein (GFP). In both experiments we observed a strong activation of SPM (mabs OX6+, SILK6+, CD40+, CD80+, CD86+) which was accompanied by a consistently increased expression of ICAM-1, VCAM-1, and the chemokines MCP-1 and MIP-1alpha.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
These observations indicate that SPM play a role in promoting lymphocyte extravasation.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Antigen specificity during an autoimmune attack is affected by antigen presentation and recognition, antigen expression and the response of target organs [1]. Accordingly, accumulating evidence shows that the extravasation of lymphocytes into the CNS perivascular (Virchow-Robin) space in the course of progressing autoimmune disease may be initiated by resident antigen presenting cells [2-4].
###end p 8
###begin p 9
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
It is generally acknowledged that, under conditions of a structurally intact blood-brain barrier, the cerebral/spinal perivascular macrophages (CPM/SPM) are the antigen presenting cells of the brain [5-9]. CPM/SPM exhibit morphological features consistent with macrophages [10], express the scavenger receptor [8], the Major Histocompatibility Complex (MHC) class II glycoproteins on their surface [6], and act as scavengers in the cerebral blood-brain interface zone [11]. CPM/SPM retain the phagocytosed material and remain within the perivascular space for up to 2 years [11], with a rather slow turnover rate of about 6% per month [12]. Due to presence of Fc and complement receptors on their surface and expression of macrophage specific antigens [5], CPM/SPM are considered to be "the only macrophages found in the tissues of the CNS" [13].
###end p 9
###begin p 10
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 274 312 274 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">membrana limitans gliae perivascularis</italic>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
CPM/SPM differ from pericytes with respect to their morphology and anatomic localization in the perivascular space [14]. Pericytes are - like elsewhere in the body - completely ensheathed by split layers of the vascular basal lamina and separated from the CNS tissue by the membrana limitans gliae perivascularis. CPM/SPM, on the contrary, are never enclosed within the basal lamina of the blood vessels. In this way, placed along the lymphatic drainage pathways of the brain, CPM/SPM are in a prime position not only for antigen presentation, but also for influencing endothelial cells and leukocyte migration from the blood [15].
###end p 10
###begin p 11
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
This is why we decided to study their role in experimental allergic encephalomyelitis (EAE), which is considered to represent an animal model for multiple sclerosis [16]. Our special interest was focused on the immunocytochemically detectable expression of cell adhesion molecules and chemokines by CPM/SPM.
###end p 11
###begin p 12
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 41 45 <span type="species:ncbi:10116">rats</span>
Observation of spinal-cord sections from rats with EAE, however, revealed numerous densely-packed mononuclear cells in the Virchow-Robin space, which seriously jeopardized the imunocytochemical differentiation between the resident SPM (mab ED2+, mab ED1+) and the recently extravasated monocytes/macrophages (mab ED1+, mab ED2-) [6,14,17].
###end p 12
###begin p 13
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
To circumvent this poor spatial and optical resolution we labeled SPM by intracerebroventricular (icv) injections of different fluorescent dyes before induction of active EAE (injection with myelin basic protein in complete Freund's adjuvant). In additional experiments EAE was induced by the intraperitoneal injection of T-cells specifically primed to myelin basic protein (MBP) and engineered to express the green fluorescent protein (GFP) [18,19].
###end p 13
###begin p 14
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
In both sets of experiments we observed a strong activation of SPM (mabs OX6+, SILK6+, CD40+, CD80+, CD86+) which was accompanied by a consistently increased expression of ICAM-1, VCAM-1, and the chemokines MCP-1 and MIP-1alpha. We conclude that, indicating the sites for lymphocytic extravasation, SPM play an important role in the initiation of local inflammatory processes.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
SPM in intact control animals
###end title 16
###begin p 17
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 93 96 <span type="species:ncbi:10116">rat</span>
###xml 124 135 <span type="species:ncbi:3704">horseradish</span>
There was no diffuse staining indicative of free marker substance in the spinal cord of both rat strains after injection of horseradish peroxidase (HRP), Fluoro-Emerald (FE), or Fluoro-Ruby (FR) in the right lateral ventricle: only the perivascular macrophages were labeled (arrows in Fig. 1).
###end p 17
###begin p 18
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 218 224 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 241 244 241 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A)</bold>
###xml 255 258 255 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B)</bold>
###xml 73 84 <span type="species:ncbi:3704">horseradish</span>
Labeling of spinal perivascular macrophages (SPM) after icv injection of horseradish peroxidase (HRP) and Fluoro-Emerald (FE). Longitudinal section through the lumbar spinal cord of intact control animals showing SPM (arrows) labeled by HRP (A) and by FE (B). 50 mum thick vibratome sections.
###end p 18
###begin title 19
###xml 7 11 <span type="species:ncbi:10116">rats</span>
SPM in rats with active EAE at the peak of paraparesis
###end title 19
###begin p 20
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 106 110 <span type="species:ncbi:10116">rats</span>
The SPM-labeling turned out to be extremely irregular after icv injection of any label in LEW/Han Rij Hsd rats at the peak of EAE (severe paraparesis). In 11 out of 21 paraplegic animals we found no labeling in the spinal cord 24 hours after icv application (Fig. 2A). Since tracers could be detected in the brain parenchyma around the injection site, we attributed their lack in the lumbar spinal cord to a blockade of the cerebrospinal-fluid circulation by the inflammatory oedema.
###end p 20
###begin p 21
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 95 97 95 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A:</bold>
###xml 234 236 233 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B:</bold>
###xml 277 283 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 385 387 383 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C:</bold>
###xml 614 616 611 613 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D:</bold>
###xml 812 814 808 810 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E:</bold>
###xml 80 84 <span type="species:ncbi:10116">rats</span>
###xml 115 118 <span type="species:ncbi:10116">rat</span>
###xml 288 292 <span type="species:ncbi:10116">rats</span>
###xml 467 471 <span type="species:ncbi:10116">rats</span>
###xml 815 818 <span type="species:ncbi:10116">Rat</span>
Labeling of spinal perivascular macrophages (SPM) after icv injection of HRP in rats with EAE. A: Spinal cord of a rat with a severe paraparesis showing large erythrocytic infiltrates but no labeling of SPM; 50 mum vibratome section. B: The successful HRP-DAB labeling of SPM (arrows) in rats with EAE reveals more labeled SPM than in normal control animals; 50 mum vibratome section. C: The dense perivascular leukocytic infiltrates in the spinal cord parenchyma of rats with severe paraparesis allow only poor spatial resolution between the endothelial and extravasated cells in 50 mum thick vibratome sections. D: No differentiation among the various types of extravasated cells filling the periavscular space was possible also in plastic semithin sections (0.5 mum thick) counterstained with toluidine blue. E: Rat with severe paraparesis. Electron micrograph showing a HRP-labeled SPM with vacuolated cytoplasm. Counterstaining with uranyl acetate and lead citrate.
###end p 21
###begin p 22
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 63 67 <span type="species:ncbi:10116">rats</span>
Observation of vibratome sections from the other 10 paraplegic rats revealed successful intensive labeling of the perivascular macrophages in both brain as well as spinal cord (arrows in Fig. 2B). Obviously in these animals the CSF-circulation was not so strongly affected by the inflammatory oedema.
###end p 22
###begin p 23
###xml 415 421 415 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C, 2D</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
Unfortunately these sections failed to provide clearcut information about the relationship between SPM and lymphocytes during extravasation. The presence of well-advanced lymphocytic infiltrates in the spinal cord parenchyma indicated that the extravasation had already occurred. No spatial resolution of the various cellular elements within these "perivascular cuffs" by conventional microscopy was possible (Fig. 2C, 2D). The electron microscopic analysis showed that a large portion of the HRP-labeled SPM contained shrunken nuclei and vacuolated scanty cytoplasm, i.e. displayed signs of degeneration (Fig. 2E).
###end p 23
###begin title 24
###xml 7 11 <span type="species:ncbi:10116">rats</span>
SPM in rats with transfer EAE at the peak of paraparesis
###end title 24
###begin p 25
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
###xml 195 198 195 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
###xml 343 349 343 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A, 3B</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 61 65 <span type="species:ncbi:10116">rats</span>
Following injection of TMBPGFP cells the syngenic LEW/CRL BR rats developed the typical monophasic course of EAE. The peak of paraparesis and incontinence was observed 5 days after injection of TMBPGFP cells. The histological examination at this period revealed a massive infiltration of the CNS with green fluorescent mononuclear cells (Fig. 3A, 3B). Their density was extremely irregular. Injection of 5% FR at the peak of paraparesis into the lateral ventricle labeled the SPM in red (Fig. 3B) and allowed unbiased observations of the relationship between SPM and infiltrating lymphocytes.
###end p 25
###begin p 26
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 124 127 124 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
###xml 138 140 138 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A:</bold>
###xml 242 254 242 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">empty arrows</italic>
###xml 301 303 301 303 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B:</bold>
###xml 337 340 337 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Vibratome section from the lumbar spinal cord of a rat in which EAE was induced by an intraperitoneal injection of 5 x 106 TMBPGFP cells. A: Five days post application (peak of paraparesis) the green fluorescent autoaggressive T-lymphocytes (empty arrows) have infiltrated both white and grey matter. B: The assumption that the bulk of TMBPGFP cells would stay in contact with the red (FR-labeled) SPM (arrows) was wrong: most lymphocytes succeeded to find a way towards the CNS parenchyma.
###end p 26
###begin p 27
###xml 289 292 289 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
These new data falsified one expectation that had been based on earlier work. Our hypothesis, that most (if not all) of the red-fluorescent SPM would be approached and contacted by the extravasated autoagressive lymphocytes, turned out to be wrong. Despite a general impression that some TMBPGFP cells adhered to SPM, most lymphocytes found a way into the CNS parenchyma through the walls of capillaries and venules which do not possess a SPM lining.
###end p 27
###begin p 28
###xml 58 61 58 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 444 520 444 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">under conditions of a non-inflammatory immune response to exogenous proteins</italic>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Thus, the invasion of leukocytes (non-labeled as well as TMBPGFP cells) occurred despite the barrier role of SPM to CNS infiltration which we had previously shown in a different kind of experiment [4]. Being a component of a neuroprotective mechanism of extraparenchymal antigen presentation and prevention of infiltrates, activated SPM can impede blood cells from crossing the lamina superficialis gliae limitans and infiltrate CNS parenchyma under conditions of a non-inflammatory immune response to exogenous proteins[4]. During EAE, however, SPM fail to stop the infiltration of CNS parenchyma by highly activated lymphocytes (primed against MBP). Obviously the degree of T cell activation, the number of activated T cells, and the localization of the target antigen in the CNS are all important factors in determining the extent of intraparenchymal T cell infiltration.
###end p 28
###begin title 29
Immunlogical pertinence of the non-phagocytic cells
###end title 29
###begin p 30
###xml 90 93 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Many non-phagocytic cells in the spinal perivascular space, which were not labeled by the icv applied fluorescent dyes, could be stained by the lymphocyte-recognizing antibodies R73, W3/25, and OX-50 (data not shown; see however Fig. 4 in Walther et al., 2001) [4].
###end p 30
###begin p 31
###xml 130 133 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 153 158 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 162 167 161 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A,C,E</bold>
###xml 187 188 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 205 206 204 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 225 226 224 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 229 234 228 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G, H:</bold>
###xml 294 305 293 304 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I, J, K, L:</bold>
###xml 322 326 321 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I, K</bold>
###xml 351 352 350 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 368 369 367 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 71 75 <span type="species:ncbi:10116">rats</span>
Activation of SPM in 50 mum vibratome sections from the spinal cord of rats with severe EAE. All cells which have been labeled by icv application of FE (green in A,C,E) are ED2-positive (B), OX6-positive (D), SILK6-positive (F). G, H: Almost all FE-labeled SPM express the CD40 molecule (CY3). I, J, K, L: FE-labeled SPM (I, K) express also the B7-1 (J) and the B7-2 (L) molecule as detected by immunofluorescence with anti-CD80, anti-CD86, and CY3.
###end p 31
###begin title 32
Activation of SPM during EAE
###end title 32
###begin p 33
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 159 176 159 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A,4C,4E,4G,4I,4K</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 281 298 278 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B,4D,4F,4H,4J,4L</xref>
###xml 629 630 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 657 658 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 438 442 <span type="species:ncbi:10116">rats</span>
###xml 509 513 <span type="species:ncbi:10116">rats</span>
Estimating the degree of activation of SPM during EAE, we found that the bulk of SPM, which were labeled and thus identified by by icv injection with FE (Fig. 4A,4C,4E,4G,4I,4K) were ED2-positive [20], expressed MHC class II glycoproteins, IL1-beta, CD40-, and B7-molecules (Figs. 4B,4D,4F,4H,4J,4L). Whereas the immunoreactivity for both the ED2-antigen and MHC class II glycoproteins is constitutive and thus present also in unaffected rats, there was no staining of SPM in spinal cord sections from intact rats after incubation with SILK6, anti-CD40, anti-CD80, anti-CD86 (data not shown; see however the right column of Fig. 3 in Walther et al., 2001) [4].
###end p 33
###begin title 34
Expression of cell adhesion molecules by SPM during EAE
###end title 34
###begin p 35
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 524 530 524 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ICAM-1</italic>
###xml 540 546 540 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VCAM-1</italic>
###xml 726 731 726 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A,5C</xref>
###xml 767 772 767 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B,5D</xref>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 455 459 <span type="species:ncbi:10116">rats</span>
###xml 715 719 <span type="species:ncbi:10116">rats</span>
To elucidate the putative chemoattracting potential of SPM, which were labeled green by an icv injection of FE, we investigated whether they expressed molecules promoting extravasation of leukocytes. Despite the common view that during ongoing inflammation the expression of adhesion molecules by the cerebral endothelium is not sufficient to support leukocyte recruitment [21-23], we compared the expression of cell adhesion molecules between unaffected rats and animals with EAE. Following incubation with polyclonal anti-ICAM-1 and anti-VCAM-1 and visualization of the immunoreaction product by the red fluorescence of Cy3, we observed much more immunopositive SPM (orange-yellow fluorescence) in the paraplegic rats (Fig. 5A,5C) than in the intact controls (Fig. 5B,5D). Although the numerous and densely-packed cells in and around the Virchow-Robin space rendered difficult the discrimination between endothelial cells, recruited macrophages and activated SPM, these results are in line with the earlier findings demonstrating expression of VCAM-1 mRNA in cerebral perivascular macrophages in the acute phase of immune-mediated injury [24].
###end p 35
###begin p 36
###xml 151 161 151 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, C, E, G</bold>
###xml 183 193 183 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B, D, F, H</bold>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 177 181 <span type="species:ncbi:10116">rats</span>
Expression of cell adhesion molecules and chemokines as revealed by double exposure pictures taken from in the lumbar spinal cord of animals with EAE (A, C, E, G) and in intact rats (B, D, F, H). SPM have been labeled and identified by icv injection of 5% FE and fluoresce in green. The reaction product expressed by SPM has been visualized by FluoroLinktrade mark Cy3trade mark-Streptavidin, which yields an orange-yellow fluorescence from the immunopositive SPM.
###end p 36
###begin title 37
Production of chemokines by SPM during EAE
###end title 37
###begin p 38
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
Chemokines are proposed to play a role in CNS inflammatory disease at the stage of leukocyte recruitment in the perivascular space in response to activated antigen-specific T-lymphocytes [25,26]. Together with their receptors the chemokines build a complex and sophisticated biochemical signaling system involved in the regulation of leukocyte and lymphocyte trafficking [27,28]. Both, adhesion molecule expression as well as production of chemokines within the CNS have been reported (reviewed in Prat et al., 2001) [29]. However, sound morphological evidence elucidating mechanism(s) by which precisely identified SPM (but not perivascular glial cells or perivascular astrocytes) could promote extravasation of leukocytes into the Virchow-Robin space and thus initiate inflammatory relapses, is still missing.
###end p 38
###begin p 39
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 185 187 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 188 190 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 284 289 272 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E,5G</xref>
###xml 345 350 333 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F,5H</xref>
###xml 210 215 <span type="species:ncbi:10090">mouse</span>
###xml 334 338 <span type="species:ncbi:10116">rats</span>
The chemokines MCP-1 (monocyte chemoattractant protein) and MIP-1alpha (macrophage inflammatory protein 1alpha) are known to play crucial roles in recruiting macrophages and monocytes [30-32]. Using monoclonal mouse antibodies we observed more MCP-1 and MIP-1alpha positive SPM (Fig. 5E,5G) in animals with EAE than in intact control rats (Fig. 5F,5H).
###end p 39
###begin title 40
Discussion
###end title 40
###begin title 41
Clinical importance of T-cell extravasation
###end title 41
###begin p 42
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">how</italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
A major issue in the pathogenesis of any autoimmune neurological disease is how autologous proteins, that had been pathologically altered "behind" an intact blood-brain barrier (BBB) can mediate T-lymphocyte entry into the central nervous system (CNS) and trigger inflammatory relapses [33]. These relapses consist of (i) early proinflammatory response, (ii) recruitment of antigen specific T-lymphocytes, and (iii) invasion of leukocytes (monocytes/macrophages, T- and B-lymphocytes) into the brain parenchyma [34-38].
###end p 42
###begin p 43
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
The last process listed, i.e. the accumulation of immune effectors around the cerebral microvasculature ("perivascular lymphocytic cuffs") is considered to initiate or exacerbate an inflammatory process, which is accompanied by a localized breakdown of the blood-brain barrier to serum proteins, leading to focal oedema [39,40]. The "bystander demyelination" [41,42], together with the subsequent interruption of axons [43,44], provide the pathologic correlate of irreversible neurologic impairment [45].
###end p 43
###begin p 44
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
In contrast, the molecular mechanisms which rule the first two processes, i.e. the proinflammatory response and the subsequent CNS-recruitment of T-lymphocytes, remain unclear. This lack of sound knowledge is very disappointing because in the course of many immune-mediated diseases such as multiple sclerosis, postinfectious encephalomyelitis, viral encephalitis, the entry of T-lymphocytes into the CNS is one of the earliest events in their pathogenesis [46-48]. Morphologically, T-lymphocytes have been shown to cross the BBB via a transendothelial route, preferentially in parajunctional areas of endothelial cells [49]. Interestingly, there appears to be a particularly high density of endothelial adhesion molecule expression in these areas [50]. Although the large number of T-lymphocytes seen in specific regions or plaques in the acute stage of multiple sclerosis suggests that there is specific targeting in the immune response [15], the basic mechanisms ruling the extravasation of lymphocytes into the perivascular (Virchow-Robin) space and the subsequent infiltration of the brain-parenchyma have not been entirely elucidated yet.
###end p 44
###begin title 45
Possible role of T-cell receptors (TCR)
###end title 45
###begin p 46
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 937 939 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
The generally accepted current theory is based on the fact that CNS is continuously patrolled by activated T-lymphocytes [49-51]. Upon antigenic stimulation to a blast phase [52] these lymphocytes which carry T cell receptors (TCR) for CNS autoantigens initiate an "encephalitogenic immune response", i.e. if these "antigen seeking" T-cells encounter their antigen in the CNS [46,52-54] they could promote an inflammatory reaction through the secretion of pro-inflammatory cytokines [55-58]. This leads to the upregulation of endothelial adhesion molecules and the local production of chemokines, which in concert facilitate the entry of circulating B- and T-lymphocytes [59] and inflammatory effector cells into the local lesion sites [60]. This "direct" or "chemotaxis-based" theory of extravasation and infiltration acknowledges the "site-specific lymphocyte entry" as a key event for the progression of disease and outcome [21,36,61-63].
###end p 46
###begin title 47
Possible role(s) of the resident antigen presenting cells
###end title 47
###begin p 48
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 417 420 <span type="species:ncbi:10116">rat</span>
Since, however, the inflammation-triggering antigen recognition by T-lymphocytes can take place only after presentation of antigen in association with the MHC class II molecule, the role of the resident antigen presenting cells (APC) during lymphocyte extravasation is a matter of continuously expanding interest [53,64-67]. Earlier work has shown that the most probable candidate for antigen presentation within the rat CNS are the ED2-positive CPM/SPM [reviewed in [68]].
###end p 48
###begin p 49
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 377 379 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 380 382 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 563 565 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 745 747 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 443 471 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 473 476 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 482 511 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 513 516 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 542 548 <span type="species:ncbi:9606">humans</span>
Due to their strategic location distal to the blood-endothelial interface and proximal to the glia limitans, CPM/SPM are able to phagocytize neuronal debris in the cerebral interstitium and to contact extravasated T-lymphocytes [9,69]. CPM/SPM synthesize MHC class II glycoproteins constitutively and, following neuronal death, transform into IL-1beta secreting neuronophages [70,71]. Recent evidence also implicates SPM as primary targets of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection in the CNS of humans and macaques [72]. Anyway, these cells must not be mixed up with other "sentinels" of the immune system within the brain, e.g. the ED2-negative dendritic cells in the meninges and choroid plexus [73].
###end p 49
###begin p 50
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 516 517 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
Accordingly, current knowledge shows that since the synthesis of T-cell receptors (TCR) is directly dependent on the concentration of MHC class II peptides expressed by APC [74], the latter are able to mediate the trafficking of specific antigen-primed T-lymphocytes [75] or B-lymphocytes [76,77] into the cerebral area. Thus, the capacity to activate lymphocytes for transfer of severe experimental autoimmune encephalomyelitis has been attributed to cerebral APC [2,75,78]. Furthermore, activating memory/blast CD4+ T-lymphocytes through secretion of cytokines [79,80] and co-stimulatory molecules, APC could play a key role in the repetitive lymphocytic invasions and leukocyte recruitment [81-83]. Finally, selective depletion of blood-borne or resident perivascular macrophages during EAE causes suppression of clinical symptoms [84-89].
###end p 50
###begin title 51
Conclusions
###end title 51
###begin p 52
In the present study we used a combination of a technique for invasive, but very reliable labeling of SPM plus an immunocytochemcal analysis of their activity status. Studying the reactivity of identified SPM in very small details, this report provides evidence for increased expression of cell adhesion molecules (ICAM-1, VCAM-1) and intensified production of chemokines (MCP-1, MIP-1alpha) by SPM during EAE. Since these findings, which could enhance T-cell extravasation, were observed in both "antigen-induced or active" and "T cell transfer-induced" forms of EAE, we suppose that they reflect a common neurobiological response of antigen-presenting SPM upon interaction with primed T-lymphocytes.
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
Animals
###end title 54
###begin p 55
###xml 374 384 374 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 41 45 <span type="species:ncbi:10116">rats</span>
###xml 181 185 <span type="species:ncbi:10116">rats</span>
###xml 317 321 <span type="species:ncbi:10116">rats</span>
Young adult (3 months of age) male Lewis rats were used: Twenty-six animals were from the strain LEW/Han Rij Hsd (purchased from Harlan Winkelmann, D-33176 Borchen, Germany) and 16 rats from the strain LEW/CRL BR (purchased from Charles River Deutschland, D-97633 Sulzfeld, Germany). Before and after experiments all rats were kept on standard laboratory food and tap water ad libitum with an artificial light-dark cycle of 12 hours light on, 12 hours light off. All experiments were conducted in accordance with the German law on Animal Protection and all procedures were approved by the Local Animal-Protection Committe (Bezirksregierung Koln, Az. 23.203.2-K 35, 33/98).
###end p 55
###begin title 56
Overview of experiments
###end title 56
###begin p 57
###xml 46 66 46 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">intact control group</bold>
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 194 205 <span type="species:ncbi:3704">horseradish</span>
###xml 225 229 <span type="species:ncbi:10116">rats</span>
###xml 270 274 <span type="species:ncbi:10116">rats</span>
###xml 285 289 <span type="species:ncbi:10116">rats</span>
Sixteen LEW/Han Rij Hsd animals comprised the intact control group and were used to optimize the labeling of spinal perivascular macrophages (SPM) by intracerebroventricular (icv) injections of horseradish peroxidase (HRP; 4 rats) or fluorochrome-conjugated dextrans (4 rats). Other 8 rats were used to immunocytochemically demonstrate the basic expression of molecules promoting SPM activation and lymphocyte extravasation.
###end p 57
###begin p 58
###xml 4 42 4 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">antigen-induced EAE (active EAE) group</bold>
###xml 59 63 <span type="species:ncbi:10116">rats</span>
The antigen-induced EAE (active EAE) group consisted of 10 rats which were used to immunocytochemically demonstrate the reactive changes in SPM during EAE.
###end p 58
###begin p 59
###xml 4 52 4 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T cell transfer-induced EAE (transfer EAE) group</bold>
###xml 194 195 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 680 683 680 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
###xml 80 84 <span type="species:ncbi:10116">rats</span>
###xml 142 146 <span type="species:ncbi:10116">rats</span>
###xml 481 485 <span type="species:ncbi:10116">rats</span>
The T cell transfer-induced EAE (transfer EAE) group consisted of 16 LEW/CRL BR rats. Eight animals were used as intact controls. The other 8 rats received an intraperitoneal injection of 5 x 106 autoaggressive MBP-specific T-lymphocytes in 3 ml 10% FCS-containing medium. Since these cells had been genetically engineered to express the green fluorescent protein (GFP), they were readily detectable within the heterogenous perivascular infiltrates ("cuffs") in the spinal cord of rats with EAE [18]. A preceeding labeling of the SPM in red fluorescence (Fluoro-Ruby) revealed the complex relationships between the resident SPM and the extravasated GFP-transduced, MBP-specific (TMBPGFP) lymphocytes.
###end p 59
###begin title 60
Labeling of SPM employing intracerebroventricular (icv) injections
###end title 60
###begin p 61
###xml 75 78 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 95 98 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 521 523 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
###xml 599 601 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B91">91</xref>
###xml 123 127 <span type="species:ncbi:10116">rats</span>
###xml 207 218 <span type="species:ncbi:3704">horseradish</span>
###xml 325 328 <span type="species:ncbi:9685">Cat</span>
After an intraperitoneal injection of Ketamin plus Xylazin (100 mg Ketanest(R) plus 5 mg Rompun(R) per kg body weight) the rats were fixed in a stereotactic apparatus and received 35 mul of a 5% solution of horseradish peroxidase (HRP, Type VIA, Sigma, No. P 6782), fluorescein-dextran (Fluoro-Emerald, FE; Molecular Probes, Cat. No. D-1820) or rhodamine-dextran (Fluoro-Ruby, FR; Molecular Probes D-1817) in 0.9% NaCl saline into the right lateral cerebral ventricle. All solutions were injected over a period of 5 min [90] using a very thin (10 mum thick) glass pipette to minimize tissue damage [91].
###end p 61
###begin title 62
Induction of experimental allergic encephalomyelitis (EAE)
###end title 62
###begin p 63
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 136 146 <span type="species:ncbi:10141">guinea pig</span>
###xml 175 201 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 230 233 <span type="species:ncbi:9685">Cat</span>
###xml 288 291 <span type="species:ncbi:31658">CFA</span>
###xml 313 316 <span type="species:ncbi:9685">Cat</span>
EAE was induced in 37 LEW/Han Rij Hsd rats by a single intradermal (hind footpad) injection containing 25 mug myelin basic protein from guinea pig (MBP; Sigma M2295), 100 mug Mycobacterium tuberculosis H37 RA (Difco Laboratories, Cat. Nr. 3114-33-8) in 50 mul Complete Freund's Adjuvant (CFA; Difco Laboratories, Cat. Nr. 0638-60-7).
###end p 63
###begin title 64
Tissue processing
###end title 64
###begin title 65
Fixation
###end title 65
###begin p 66
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
###xml 4 8 <span type="species:ncbi:10116">rats</span>
All rats were anesthetized with ether, their vascular system rinsed for 60 sec with 0.9% NaCl saline and fixed for at least 40 min by transcardial perfusion with 1.0 litre of periodate-lysine-paraformaldehyde (PLP) fixative [92]. The PLP fixative was separately mixed from premade stem stock solutions immediately prior to the perfusion of each animal. The CNS (cerebrum, cerebellum, brainstem, spinal cord) was removed and stored in a 4% (w/v) paraformaldehyde in 0.1 M phosphate buffer, pH 7,4.
###end p 66
###begin title 67
Visualizing of HRP-labeled SPM
###end title 67
###begin p 68
###xml 34 35 34 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 493 494 492 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 495 496 494 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 861 862 860 861 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 871 872 870 871 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 872 875 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">III</sup>
###xml 881 882 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 883 885 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
In contrast to our previous work [4] we focused our observations on the lumbar spinal cord only: Since the major visible symptom during EAE is the severe paraparesis of the hind limbs, most of the pathological alterations should be expected, localized and observed in this region. Longitudinal vibratome sections (50 mum thick) of the spinal cord were incubated for 20 min in 0.75% (w/v) 3,3'-diaminobenzidine tetrahydrochloride (150 mg in 200 ml buffer; DAB, Sigma, D 5637) plus 0.01% (v/v) H2O2 plus 0.075% (w/v) nickel chloride in 0.05 M Tris-HCl buffer, pH 7.6. This procedure yielded a very intensive dark-purple to black reaction product exclusively in the cytoplasm of the SPM. Control tissue (sections from brains which had not received HRP injections) contained no reaction product. For electron microscopy some of the sections were postfixed in 1% OsO4 + 1.5% K3IIIFe(CN)6[93], dehydrated in graded acetones, and embedded flat in Araldite CY212 (Fluka, No. 44610).
###end p 68
###begin title 69
Visualizing of FE- and FR-labeled SPM
###end title 69
###begin p 70
To detect the green fluorescence of FE or the red fluorescence of FR vibratome sections (50 mum thick) of the spinal cord were illuminated through filter set 10 (excitation BP 450-490, beamsplitter FT 510, emission BP 515-565) or filter set 15 (Excitation BP 546/12, Emission LP 590) of a Carl Zeiss microscope.
###end p 70
###begin title 71
Immunocytochemistry
###end title 71
###begin title 72
Primary antibodies
###end title 72
###begin p 73
###xml 4 9 <span type="species:ncbi:10090">Mouse</span>
###xml 64 67 <span type="species:ncbi:10116">rat</span>
###xml 99 104 <span type="species:ncbi:10090">Mouse</span>
###xml 174 177 <span type="species:ncbi:10116">rat</span>
###xml 192 208 <span type="species:ncbi:10032">Armenian hamster</span>
###xml 225 230 <span type="species:ncbi:10090">mouse</span>
###xml 335 340 <span type="species:ncbi:10090">Mouse</span>
###xml 448 451 <span type="species:ncbi:10116">rat</span>
###xml 461 466 <span type="species:ncbi:10090">Mouse</span>
###xml 574 577 <span type="species:ncbi:10116">rat</span>
###xml 598 603 <span type="species:ncbi:10090">mouse</span>
###xml 609 612 <span type="species:ncbi:10116">rat</span>
###xml 749 754 <span type="species:ncbi:10090">mouse</span>
###xml 760 763 <span type="species:ncbi:10116">rat</span>
###xml 916 921 <span type="species:ncbi:10090">mouse</span>
###xml 927 930 <span type="species:ncbi:10116">rat</span>
###xml 1091 1095 <span type="species:ncbi:9925">goat</span>
###xml 1101 1104 <span type="species:ncbi:10116">rat</span>
###xml 1176 1179 <span type="species:ncbi:10116">rat</span>
###xml 1231 1235 <span type="species:ncbi:9925">goat</span>
###xml 1241 1244 <span type="species:ncbi:10116">rat</span>
###xml 1316 1319 <span type="species:ncbi:10116">rat</span>
###xml 1371 1377 <span type="species:ncbi:9986">rabbit</span>
###xml 1383 1386 <span type="species:ncbi:10116">rat</span>
###xml 1570 1576 <span type="species:ncbi:9986">rabbit</span>
###xml 1582 1585 <span type="species:ncbi:10116">rat</span>
(1) Mouse monoclonal OX-6 (Serotec, MCA 46, 1:1000) recognizing rat MHC class II (Ia) antigen. (2) Mouse monoclonal SILK 6 (Serotec, MCA-1397, 1:500) recognizing recombinant rat IL-1beta. (3) Armenian hamster monoclonal anti-mouse CD40 (BD PharMingen, 09401A, 1:100) to test for presence of the costimulatory molecule CD40 on SPM. (4) Mouse monoclonal CD80 (BD PharMingen, 22661D, 1:100) to test for presence of the co-stimulatory molecule B7-1 on rat SPM. (5) Mouse monoclonal CD86 (BD PharMingen, 22671D, 1:100) to test for presence of the co-stimulatory molecule B7-2 on rat SPM. (6) Monoclonal mouse anti-rat TCR alpha/beta (clone R73, Serotec MCA 453G, 1:20) recognizing a constant determinant of the alpha/beta T cell receptor. (7) Monoclonal mouse anti-rat CD4 (clone number W3/25, Serotec MCA55G, 1:50) recognizing the CD4 cell surface glycoprotein expressed by helper T cells and thymocytes. (8) Monoclonal mouse anti-rat CD44 (clone OX-50, Serotec MCA643XZ, 1:50) recognizing the CD44 cell surface antigen expressed by T cells, B cells, macrophages, and thymocytes. (9) Polyclonal goat anti-rat ICAM-1(M-19; Santa Cruz Biotechnology Inc., sc-1511, 1:50) recognizing rat intercellular adhesion molecule-1. (10) Polyclonal goat anti-rat VCAM-1(C-19; Santa Cruz Biotechnology Inc., sc-1504, 1:50) recognizing rat vascular cell adhesion molecule-1. (11) Polyclonal rabbit anti-rat MCP-1 (Cedarlane, No. CL9576AP, 1:500). recognizing the CC-chemokine "monocyte chemoattractant protein-1" which promotes the directed migration of inflammatory cells. (12) Polyclonal rabbit anti-rat MIP-1alpha (Cedarlane, No. CL9577AP, 1:2000) recognizing the chemokine "macrophage inflammatory protein-1alpha ".
###end p 73
###begin title 74
Secondary antibodies
###end title 74
###begin p 75
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 17 21 <span type="species:ncbi:9925">goat</span>
###xml 27 33 <span type="species:ncbi:9986">rabbit</span>
###xml 74 78 <span type="species:ncbi:9925">goat</span>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 142 146 <span type="species:ncbi:9925">goat</span>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
###xml 194 199 <span type="species:ncbi:9606">human</span>
###xml 208 211 <span type="species:ncbi:10116">rat</span>
###xml 265 271 <span type="species:ncbi:9986">rabbit</span>
###xml 277 281 <span type="species:ncbi:9925">goat</span>
###xml 428 431 <span type="species:ncbi:10116">rat</span>
###xml 477 482 <span type="species:ncbi:10090">mouse</span>
(1) Biotinylated goat anti-rabbit IgG (DAKO, No. E0432). (2) Biotinylated goat anti-mouse IgG (Fab-specific, Sigma, B-0529). (3) Biotinylated goat anti-mouse IgG (Fc specific, pre-absorbed with human IgG and rat serum proteins, Sigma, No. B-9904). (4) Biotinylated rabbit anti-goat IgG (DAKO, No. E0466). In order to minimize the background staining of neurons the biotinylated IgGs were always pre-absorbed with the individual rat's spleen protein [70]. (5) Biotin-conjugated mouse anti-hamster IgG (cocktail; PharMingen, 12102D).
###end p 75
###begin title 76
Standard incubation protocol
###end title 76
###begin p 77
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 131 132 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 216 222 <span type="species:ncbi:9913">bovine</span>
###xml 415 419 <span type="species:ncbi:9925">goat</span>
###xml 461 467 <span type="species:ncbi:9986">rabbit</span>
Free floating vibratome sections were immunostained on a shaker at room temperature through the following steps: (1) 0.6% (v/v) H2O2 in buffer (to block the endogenous peroxidase activity) for 30 min; (2) 5.0% (w/v) bovine serum albumin (BSA, Sigma No. A-9647) in 0.1 M Tris-buffered saline (TBS) pH 7.6 for 60 min; (3) primary antibody (see above) diluted in TBS plus 0.8% (w/v) BSA for 2 h; (4) 5.0% (v/v) normal goat serum (NGS, Vector No. S-1000) or normal rabbit serum (NRS, DAKO, No. X0902) plus 0.8% BSA in TBS for 15 min. (5) 1:400 dilution of the corresponding biotinylated secondary antibody in TBS for 1 h; (6) 1:100 diluted FluoroLinktrade mark Cy2trade mark-Streptavidin (Amersham Life Science, PA 42001) or FluoroLinktrade mark Cy3trade mark-Streptavidin (Amersham Life Science, PA 43001) for 1 h. Steps (1) and (5) were followed by two 10 min washes in TBS. Steps (3) and (6) were followed by four 10 min washes in TBS. Finally, sections were dehydrated with ethanol and Histoclear (a nontoxic xylene-substitute) and coverslipped.
###end p 77
###begin title 78
Controls
###end title 78
###begin p 79
###xml 190 194 <span type="species:ncbi:9925">goat</span>
###xml 200 206 <span type="species:ncbi:9986">rabbit</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
Omission of the primary or secondary antibody yielded blank sections in which only the green SPM fluoresced. Incubation of sections with non-relevant biotinylated secondary antibodies (e.g. goat anti-rabbit IgG for recognition of mouse primary antibodies) yielded also blank sections.
###end p 79
###begin title 80
Fluorescence microscopy
###end title 80
###begin p 81
FE-labeled SPM and Cy2-immunopositive cells were visualized through filter set 10 of a Carl Zeiss fluorescence microscope. FR-labeled SPM and Cy3-immunopositive cells were observed through Zeiss filter set 15 (excitation BP546/12, beamsplitter FT580, emission LP590). Both FE-labeled SPM and CY3-immunopositive cells could be simultaneously observed employing Zeiss filter set 25 (excitation TBP400/495/570, beamsplitter FT410/505/585, emission TBP460/530/610).
###end p 81
###begin title 82
Authors' contributions
###end title 82
###begin p 83
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
###xml 192 195 192 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">icv</italic>
N.H. participated in the icv labelings and counts of the SPP. N.L. performed the immunocytochemistry. M.S. participated in the icv labelings. B.W. performed the intraperitoneal injections of TMBPGFP lymphocytes. W.F.N. participated in the coordination of the study. O.G.L. participated in the icv labelings. D.N.A. designed the study, induced EAE, participated in the icv labelings and perfused the animals.
###end p 83
###begin p 84
All authors read and approved the final manuscript.
###end p 84
###begin title 85
Acknowledgements
###end title 85
###begin p 86
###xml 297 300 297 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MBP</sub>
This work has been financially supported by the Imhoff-Foundation (D.N.A.), the Jean Uhrmacher-Foundation (O.G.-L.), and the Megapharm GmbH, Germany (M.S.). The authors are thankful to Dr. Alexander Flugel (Max-Planck-Institut fur Neurobiologie, Martinsried, Germany) for the generously provided TMBPGFP cells. The skillful technical assistance of Mrs. Ilona Rohrmann and Mrs. Dirkje Felder and the fine photographical work of Mrs. Inge Koch are highly appreciated.
###end p 86
###begin article-title 87
Autoimmune disease:why and where it occurs.
###end article-title 87
###begin article-title 88
A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation.
###end article-title 88
###begin article-title 89
Pathogenetic role of autoantibodies in neurological disease.
###end article-title 89
###begin article-title 90
Exogenous antigen containing perivascular phagocytes induce a non-encephalitogenic extravasation of primed lymphocytes.
###end article-title 90
###begin article-title 91
Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo.
###end article-title 91
###begin article-title 92
###xml 47 50 <span type="species:ncbi:10116">rat</span>
Identity of ED2-positive perivascular cells in rat brain.
###end article-title 92
###begin article-title 93
###xml 129 134 <span type="species:ncbi:9606">human</span>
Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain
###end article-title 93
###begin article-title 94
Involvement of specific macrophage-lineage cell surrounding arterioles in barrier and scavenger function in brain cortex.
###end article-title 94
###begin article-title 95
The cerebral perivascular cells.
###end article-title 95
###begin article-title 96
Identification of microglia in light and electron microscopy.
###end article-title 96
###begin article-title 97
Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages.
###end article-title 97
###begin article-title 98
###xml 12 15 <span type="species:ncbi:10116">rat</span>
Turnover of rat brain perivascular cells.
###end article-title 98
###begin article-title 99
Macrophage heterogeneity established by immunocytochemistry.
###end article-title 99
###begin article-title 100
New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury.
###end article-title 100
###begin article-title 101
Lymphocyte targeting of the central nervous system: A review of afferent and efferent CNS-immune pathways.
###end article-title 101
###begin article-title 102
The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion.
###end article-title 102
###begin article-title 103
###xml 30 33 <span type="species:ncbi:10116">rat</span>
Monoclonal antibodies against rat macrophages.
###end article-title 103
###begin article-title 104
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses.
###end article-title 104
###begin article-title 105
New tools to trace populations of inflammatory cells in the CNS.
###end article-title 105
###begin article-title 106
###xml 106 109 <span type="species:ncbi:10116">rat</span>
The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.
###end article-title 106
###begin article-title 107
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Cell-adhesion molecules on vessels during inflammation in the mouse central nervous system
###end article-title 107
###begin article-title 108
###xml 32 38 <span type="species:ncbi:10090">murine</span>
Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammogen or during acute neuronal degeneration
###end article-title 108
###begin article-title 109
Inflamation in the nervous system.
###end article-title 109
###begin article-title 110
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Vascular cell adhesion molecule-1 mRNA is expressed in immune-mediated and ischemic injury of the rat nervous system.
###end article-title 110
###begin article-title 111
Chemokines in immune-mediated inflammation of the central nervous system.
###end article-title 111
###begin article-title 112
Chemokines and chemokine receptors in model neurological pathologies: Molecular and immunohistochemical approaches.
###end article-title 112
###begin article-title 113
Immune function of microglia.
###end article-title 113
###begin article-title 114
Chemokines in pathology and medicine.
###end article-title 114
###begin article-title 115
###xml 28 33 <span type="species:ncbi:9606">human</span>
Glial cell influence on the human blood-brain-barrier.
###end article-title 115
###begin article-title 116
###xml 48 51 <span type="species:ncbi:10116">rat</span>
Production of Monocyte Chemotactic Protein-1 by rat brain macrophages.
###end article-title 116
###begin article-title 117
Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis.
###end article-title 117
###begin article-title 118
###xml 57 62 <span type="species:ncbi:9606">human</span>
Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS.
###end article-title 118
###begin article-title 119
Cellular immune reactivity within the CNS.
###end article-title 119
###begin article-title 120
###xml 140 143 <span type="species:ncbi:10116">rat</span>
Graft-vs-host disease elicits expression of class I and class II hostocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system.
###end article-title 120
###begin article-title 121
Neuroimmunologic diseases: Effector cell responses and immunoregulatory mechanisms.
###end article-title 121
###begin article-title 122
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration.
###end article-title 122
###begin article-title 123
The role of microglia and macrophages in the pathophysiology of the CNS.
###end article-title 123
###begin article-title 124
Neuronal FasL induces cell death of encephalithogenic T lymphocytes.
###end article-title 124
###begin article-title 125
Mechanism of autoimmune neuropathies.
###end article-title 125
###begin article-title 126
Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
###end article-title 126
###begin article-title 127
Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis.
###end article-title 127
###begin article-title 128
Primary demyelination as a non-specific consequence of a cell-mediated immune reaction.
###end article-title 128
###begin article-title 129
Axonal damage in acute multiple sclerosis lesions.
###end article-title 129
###begin article-title 130
Axonal transection in the lesions of multiple sclerosis.
###end article-title 130
###begin article-title 131
The role of macrophages in the immune-mediated damage to the peripheral nervous system.
###end article-title 131
###begin article-title 132
T-lymphocyte entry into the central nervous system.
###end article-title 132
###begin article-title 133
Microglial cells are a component of the perivascular glia limitans.
###end article-title 133
###begin article-title 134
Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis.
###end article-title 134
###begin article-title 135
Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.
###end article-title 135
###begin article-title 136
Inflammation in the nervous system.
###end article-title 136
###begin article-title 137
Characterization of inflammatory infiltrates in experimental allergic encephalomyelitis.
###end article-title 137
###begin article-title 138
Basic principles of immunological surveillance of the normal central nervous system.
###end article-title 138
###begin article-title 139
Homing to central nervous system vasculature by antigen specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic and relapsing experimental allergic encephalomyelitis.
###end article-title 139
###begin article-title 140
Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation.
###end article-title 140
###begin article-title 141
###xml 46 49 <span type="species:ncbi:10116">rat</span>
Comparison of the immunological properties of rat cerebral and aortic endothelium.
###end article-title 141
###begin article-title 142
Experimental autoimmune encephalomyelitis: the antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system.
###end article-title 142
###begin article-title 143
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice.
###end article-title 143
###begin article-title 144
The immune system.
###end article-title 144
###begin article-title 145
###xml 54 57 <span type="species:ncbi:10116">rat</span>
Antigen-dependent intrathecal synthesis in the normal rat brain: tissue entry and local retention of antigen specific B cells.
###end article-title 145
###begin article-title 146
Basic mechanisms of brain inflammation.
###end article-title 146
###begin article-title 147
Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis.
###end article-title 147
###begin article-title 148
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord.
###end article-title 148
###begin article-title 149
Leukocyte chemotactic factor, a natural ligand to CD4, is expressed by lymphocytes and microglial cells of the MS plaque.
###end article-title 149
###begin article-title 150
Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis.
###end article-title 150
###begin article-title 151
###xml 23 42 <span type="species:ncbi:12455">Borna disease virus</span>
Intrinsic responses to Borna disease virus infection of the central nervous system.
###end article-title 151
###begin article-title 152
###xml 54 58 <span type="species:ncbi:10116">rats</span>
Microvascular and cellular responses in the retina of rats with acute experimental allergic encephalomyelitis (EAE).
###end article-title 152
###begin article-title 153
CP-10, a chemotactic peptide, is expressed in lesions of experimental autoimmune encephalomyelitis, neuritis, uveitis and in C6 gliomas.
###end article-title 153
###begin article-title 154
Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function.
###end article-title 154
###begin article-title 155
###xml 41 44 <span type="species:ncbi:10116">rat</span>
Mechanisms of allograft rejection in the rat brain.
###end article-title 155
###begin article-title 156
###xml 111 114 <span type="species:ncbi:10116">rat</span>
ED2-positive perivascular cells act as neuronophages during delayed neuronal loss in the facial nucleus of the rat.
###end article-title 156
###begin article-title 157
###xml 124 127 <span type="species:ncbi:10116">rat</span>
ED2-positive perivascular neuronophages produce Interleukin-1beta during delayed neuronal loss in the facial nucleus of the rat.
###end article-title 157
###begin article-title 158
###xml 76 105 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.
###end article-title 158
###begin article-title 159
###xml 138 141 <span type="species:ncbi:10116">rat</span>
Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations.
###end article-title 159
###begin article-title 160
The immunological synapse: a molecular machine controlling T cell activation.
###end article-title 160
###begin article-title 161
###xml 36 39 <span type="species:ncbi:10116">rat</span>
Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.
###end article-title 161
###begin article-title 162
###xml 96 111 <span type="species:ncbi:10090">transgenic mice</span>
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice.
###end article-title 162
###begin article-title 163
B cells and antibodies in CNS demyelinating disease.
###end article-title 163
###begin article-title 164
###xml 6 9 <span type="species:ncbi:10116">rat</span>
Lewis rat lymphoid dendritic cells can efficiently present homologous myelin basic protein to encephalitogenic lymphocytes.
###end article-title 164
###begin article-title 165
Interleukin 1: more than a mediator between leukocytes.
###end article-title 165
###begin article-title 166
Accessory molecule and costimulation requirements for CD4 T cell response.
###end article-title 166
###begin article-title 167
Ia restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes.
###end article-title 167
###begin article-title 168
Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T-cells under in vivo mimicking conditions.
###end article-title 168
###begin article-title 169
Mechanisms of immune injury in multiple sclerosis.
###end article-title 169
###begin article-title 170
The effect of macrophage depletion on clinical and pathological expression of experimental allergic encephalomyelitis.
###end article-title 170
###begin article-title 171
The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis.
###end article-title 171
###begin article-title 172
###xml 64 68 <span type="species:ncbi:10116">rats</span>
Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.
###end article-title 172
###begin article-title 173
###xml 125 129 <span type="species:ncbi:10116">rats</span>
Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewin rats.
###end article-title 173
###begin article-title 174
###xml 183 187 <span type="species:ncbi:10090">mice</span>
Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage depleted mice.
###end article-title 174
###begin article-title 175
The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis.
###end article-title 175
###begin article-title 176
###xml 27 38 <span type="species:ncbi:3704">horseradish</span>
Penetration and removal of horseradish peroxidase injected into the cerebrospinal fluid: role of cerebral perivascular spaces, endothelium and microglia.
###end article-title 176
###begin article-title 177
###xml 42 45 <span type="species:ncbi:10116">rat</span>
In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines.
###end article-title 177
###begin article-title 178
Periodate-lysine-paraformaldehyde fixative a new fixative for immunoelectron microscopy.
###end article-title 178
###begin article-title 179
The use of potassium ferricyanide in neural fixation.
###end article-title 179

